Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease

The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide; however, there are currently limited treatments for NAFLD. The disease spectrum includes simple fatty liver, non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and progression to hepatocellular carcin...

Full description

Bibliographic Details
Main Authors: Panli Tan, Li Jin, Xiang Qin, Beihui He
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1005312/full
_version_ 1828145054877745152
author Panli Tan
Li Jin
Xiang Qin
Beihui He
author_facet Panli Tan
Li Jin
Xiang Qin
Beihui He
author_sort Panli Tan
collection DOAJ
description The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide; however, there are currently limited treatments for NAFLD. The disease spectrum includes simple fatty liver, non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and progression to hepatocellular carcinoma (NASH-HCC). The therapeutic effects of NAFLD remain controversial. Although researchers have conducted studies on the pathogenesis of NAFLD, its pathogenesis and anti-NAFLD mechanisms have not been fully elucidated. Previous studies have found that flavonoids, as natural substances with extensive pharmacological activity and good therapeutic effects, have excellent antioxidant, anti-inflammatory, metabolic disease improvement, anti-tumor, and other properties and can significantly alleviate NAFLD. Flavonoids could be further developed as therapeutic drugs for NAFLD. In this paper, the pathogenesis of NAFLD and the mechanisms of flavonoids against NAFLD are summarized to provide a theoretical basis for screening flavonoids against non-alcoholic liver injury.
first_indexed 2024-04-11T20:26:26Z
format Article
id doaj.art-cf9dc4a60bd44061ae549db07a14a151
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T20:26:26Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-cf9dc4a60bd44061ae549db07a14a1512022-12-22T04:04:39ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-09-011310.3389/fphar.2022.10053121005312Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver diseasePanli Tan0Li Jin1Xiang Qin2Beihui He3The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, ChinaSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, ChinaThe incidence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide; however, there are currently limited treatments for NAFLD. The disease spectrum includes simple fatty liver, non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and progression to hepatocellular carcinoma (NASH-HCC). The therapeutic effects of NAFLD remain controversial. Although researchers have conducted studies on the pathogenesis of NAFLD, its pathogenesis and anti-NAFLD mechanisms have not been fully elucidated. Previous studies have found that flavonoids, as natural substances with extensive pharmacological activity and good therapeutic effects, have excellent antioxidant, anti-inflammatory, metabolic disease improvement, anti-tumor, and other properties and can significantly alleviate NAFLD. Flavonoids could be further developed as therapeutic drugs for NAFLD. In this paper, the pathogenesis of NAFLD and the mechanisms of flavonoids against NAFLD are summarized to provide a theoretical basis for screening flavonoids against non-alcoholic liver injury.https://www.frontiersin.org/articles/10.3389/fphar.2022.1005312/fullnon-alcoholic fatty liver diseasenatural flavonoids, antioxidant, anti-inflammatoryintestinal floraoxidat ive stressinflammtion
spellingShingle Panli Tan
Li Jin
Xiang Qin
Beihui He
Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
Frontiers in Pharmacology
non-alcoholic fatty liver disease
natural flavonoids, antioxidant, anti-inflammatory
intestinal flora
oxidat ive stress
inflammtion
title Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
title_full Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
title_fullStr Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
title_full_unstemmed Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
title_short Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
title_sort natural flavonoids potential therapeutic strategies for non alcoholic fatty liver disease
topic non-alcoholic fatty liver disease
natural flavonoids, antioxidant, anti-inflammatory
intestinal flora
oxidat ive stress
inflammtion
url https://www.frontiersin.org/articles/10.3389/fphar.2022.1005312/full
work_keys_str_mv AT panlitan naturalflavonoidspotentialtherapeuticstrategiesfornonalcoholicfattyliverdisease
AT lijin naturalflavonoidspotentialtherapeuticstrategiesfornonalcoholicfattyliverdisease
AT xiangqin naturalflavonoidspotentialtherapeuticstrategiesfornonalcoholicfattyliverdisease
AT beihuihe naturalflavonoidspotentialtherapeuticstrategiesfornonalcoholicfattyliverdisease